Cargando…

Cutaneous manifestations in patients with end-stage renal disease on hemodialysis

BACKGROUND: End-stage renal disease (ESRD) is a serious chronic disease that affects many organ systems. Skin manifestations that are commonly seen in ESRD can significantly impair the quality of life in these patients. Early recognition and management of mucocutaneous disorders can improve quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirzadian Kebria, Azar, Aryanian, Zeinab, Choobdar, Amin, Akbari, Roghayeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646361/
https://www.ncbi.nlm.nih.gov/pubmed/38024163
http://dx.doi.org/10.22088/cjim.14.4.728
_version_ 1785134880956350464
author Shirzadian Kebria, Azar
Aryanian, Zeinab
Choobdar, Amin
Akbari, Roghayeh
author_facet Shirzadian Kebria, Azar
Aryanian, Zeinab
Choobdar, Amin
Akbari, Roghayeh
author_sort Shirzadian Kebria, Azar
collection PubMed
description BACKGROUND: End-stage renal disease (ESRD) is a serious chronic disease that affects many organ systems. Skin manifestations that are commonly seen in ESRD can significantly impair the quality of life in these patients. Early recognition and management of mucocutaneous disorders can improve quality of life and decrease morbidity. This study aimed to evaluate the skin manifestations in ESRD patients undergoing hemodialysis. METHODS: In this cross-sectional study 150 patients undergoing hemodialysis in the Nephrology Department of Shahid-Beheshti Hospital in Babol were enrolled. The demographic and clinical data were assessed. Analysis was done by SPSS 22 and significance level was under 0.05. RESULTS: The mean duration of hemodialysis was 8.7 months. The most common skin findings in patients include xerosis 84.7%, pallor 82.7%, pruritus 67.3%, hyperpigmentation 40%, purpura 28%. Skin infections were detected in 36% of patients (fungal 28%, bacterial 10.7%, and viral 5.3%). Nail, hair and mucosal changes were observed among 65.3%, 38% and 17.3% of patients respectively. No significant correlation was detected between skin findings and duration of dialysis. CONCLUSION: The findings of the present study showed that skin manifestations are highly prevalent among patients with ESRD. Prompt diagnosis and management of the dermatological disorders may improve the quality of life in the affected patients.
format Online
Article
Text
id pubmed-10646361
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Babol University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-106463612023-09-01 Cutaneous manifestations in patients with end-stage renal disease on hemodialysis Shirzadian Kebria, Azar Aryanian, Zeinab Choobdar, Amin Akbari, Roghayeh Caspian J Intern Med Original Article BACKGROUND: End-stage renal disease (ESRD) is a serious chronic disease that affects many organ systems. Skin manifestations that are commonly seen in ESRD can significantly impair the quality of life in these patients. Early recognition and management of mucocutaneous disorders can improve quality of life and decrease morbidity. This study aimed to evaluate the skin manifestations in ESRD patients undergoing hemodialysis. METHODS: In this cross-sectional study 150 patients undergoing hemodialysis in the Nephrology Department of Shahid-Beheshti Hospital in Babol were enrolled. The demographic and clinical data were assessed. Analysis was done by SPSS 22 and significance level was under 0.05. RESULTS: The mean duration of hemodialysis was 8.7 months. The most common skin findings in patients include xerosis 84.7%, pallor 82.7%, pruritus 67.3%, hyperpigmentation 40%, purpura 28%. Skin infections were detected in 36% of patients (fungal 28%, bacterial 10.7%, and viral 5.3%). Nail, hair and mucosal changes were observed among 65.3%, 38% and 17.3% of patients respectively. No significant correlation was detected between skin findings and duration of dialysis. CONCLUSION: The findings of the present study showed that skin manifestations are highly prevalent among patients with ESRD. Prompt diagnosis and management of the dermatological disorders may improve the quality of life in the affected patients. Babol University of Medical Sciences 2023 /pmc/articles/PMC10646361/ /pubmed/38024163 http://dx.doi.org/10.22088/cjim.14.4.728 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Shirzadian Kebria, Azar
Aryanian, Zeinab
Choobdar, Amin
Akbari, Roghayeh
Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
title Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
title_full Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
title_fullStr Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
title_full_unstemmed Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
title_short Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
title_sort cutaneous manifestations in patients with end-stage renal disease on hemodialysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646361/
https://www.ncbi.nlm.nih.gov/pubmed/38024163
http://dx.doi.org/10.22088/cjim.14.4.728
work_keys_str_mv AT shirzadiankebriaazar cutaneousmanifestationsinpatientswithendstagerenaldiseaseonhemodialysis
AT aryanianzeinab cutaneousmanifestationsinpatientswithendstagerenaldiseaseonhemodialysis
AT choobdaramin cutaneousmanifestationsinpatientswithendstagerenaldiseaseonhemodialysis
AT akbariroghayeh cutaneousmanifestationsinpatientswithendstagerenaldiseaseonhemodialysis